


Products & Services
2022-02-22
GemPharmatech proudly partnered with Fierce Biotech to bring you our most recent webinar, Moving from Discovery to Clinic with Genetically Engineered Mouse Models. In this compelling webinar Dr. Mark Moore and Dr. Santi Suryani Chen discuss the importance and value of using genetically modified mouse models (GEMMs) to accelerate preclinical research from discovery to the clinic. Specifically, they share information about screening methods and generating safety and efficacy data using conditional knockout mice, humanized immune checkpoint mice, and immunocompromised mouse models.
Please click here to visit Fierce Biotech's website where you can register to watch the webinar on-demand.
More infomation about blogs

Let us know which event you're attending and we'd be happy to connect with you.
This website will store cookies on your computer. These cookies are used to collect information about how you interact with this website and enable us to remember you. We use this information to improve and customize your browsing experience, as well as to analyze and collect relevant data and metrics about visitors on this website and other platforms. For more information about the cookies we use, please refer to our privacy policy
If you decline, your information will not be tracked when visiting this website. A cookie will be used in your browser to remember your preference settings that you have not accepted.
